These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 23009795)

  • 61. Polymorphisms of TNF-
    Wu CC; Huang YK; Huang CY; Shiue HS; Pu YS; Su CT; Lin YC; Hsueh YM
    Biomed Res Int; 2018; 2018():3148137. PubMed ID: 29951534
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
    Shen BL; Qu QS; Miao SZ; Zhang YX
    Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study.
    Pommer W; Bronder E; Klimpel A; Helmert U; Greiser E; Molzahn M
    Nephrol Dial Transplant; 1999 Dec; 14(12):2892-7. PubMed ID: 10570093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Chang CH; Liu CS; Liu HJ; Huang CP; Huang CY; Hsu HT; Liou SH; Chung CJ
    Int J Urol; 2016 Mar; 23(3):233-9. PubMed ID: 26663353
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma.
    Liu F; Wen T; Tang Q; Chen F; Liao D
    Nephron; 2020; 144(5):255-260. PubMed ID: 32182617
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polymorphisms in GSTT1 and p53 and urinary transitional cell carcinoma in south-western Taiwan: a preliminary study.
    Chen YC; Xu L; Guo YL; Su HJ; Smith TJ; Ryan LM; Lee MS; Christiani DC
    Biomarkers; 2004; 9(4-5):386-94. PubMed ID: 15764300
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer.
    Yang H; Wang Z; Guo Y; Wang Z
    Dis Markers; 2015; 2015():383509. PubMed ID: 26798188
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke.
    Rahmani A; Alzohairy M; Khadri H; Mandal AK; Rizvi MA
    Int J Clin Exp Pathol; 2012; 5(3):195-202. PubMed ID: 22558473
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
    Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A
    Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationships among DNA hypomethylation, Cd, and Pb exposure and risk of cigarette smoking-related urothelial carcinoma.
    Chung CJ; Chang CH; Liou SH; Liu CS; Liu HJ; Hsu LC; Chen JS; Lee HL
    Toxicol Appl Pharmacol; 2017 Feb; 316():107-113. PubMed ID: 28025111
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Djukic T; Simic T; Radic T; Matic M; Pljesa-Ercegovac M; Suvakov S; Coric V; Pekmezovic T; Novakovic I; Dragicevic D; Savic-Radojevic A
    Int Urol Nephrol; 2015 Apr; 47(4):625-30. PubMed ID: 25716313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A case-control study of smoking and bladder cancer risk: emergent patterns over time.
    Baris D; Karagas MR; Verrill C; Johnson A; Andrew AS; Marsit CJ; Schwenn M; Colt JS; Cherala S; Samanic C; Waddell R; Cantor KP; Schned A; Rothman N; Lubin J; Fraumeni JF; Hoover RN; Kelsey KT; Silverman DT
    J Natl Cancer Inst; 2009 Nov; 101(22):1553-61. PubMed ID: 19917915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Blood cadmium may be associated with bladder carcinogenesis: the Belgian case-control study on bladder cancer.
    Kellen E; Zeegers MP; Hond ED; Buntinx F
    Cancer Detect Prev; 2007; 31(1):77-82. PubMed ID: 17296271
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
    Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
    Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population.
    Luo T; Chen L; He P; Hu QC; Zhong XR; Sun Y; Yang YF; Tian TL; Zheng H
    Asian Pac J Cancer Prev; 2013; 14(4):2433-7. PubMed ID: 23725153
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Smoking, occupation, history of selected diseases and bladder cancer risk in Manisa, Turkey.
    Erdurak K; Dundar PE; Ozyurt BC; Negri E; La Vecchia C; Tay Z
    Eur J Cancer Prev; 2014 Jan; 23(1):58-61. PubMed ID: 23788017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers.
    Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
    DNA Cell Biol; 2007 Jul; 26(7):453-63. PubMed ID: 17630849
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
    Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
    J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt.
    Wolpert BJ; Amr S; Saleh DA; Ezzat S; Gouda I; Loay I; Hifnawy T; Abdel-Hamid M; Mikhail NN; Zhan M; Zheng YL; Squibb K; Abdel-Aziz MA; Zaghloul MS; Khaled H; Loffredo CA
    Urol Oncol; 2012; 30(6):841-7. PubMed ID: 21397529
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Epidemiology of and risk factors for bladder cancer and for urothelial tumors].
    Guillaume L; Guy L
    Rev Prat; 2014 Dec; 64(10):1372-4, 1378-80. PubMed ID: 25668830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.